Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

En Shu

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Life (Basel, Switzerland)|March 25, 2022
α2-Antiplasmin as a Potential Therapeutic Target for Systemic SclerosisYosuke Kanno, En Shu
The Journal of Dermatology|July 22, 2014
Scleroderma renal crisis following pericardial effusion in a Japanese femaleEn Shu, Hiroyuki Kanoh, Mariko Seishima
Molecular Medicine Reports|September 18, 2020
Decrease in matrix metalloproteinase‑3 activity in systemic sclerosis fibroblasts causes α2‑antiplasmin and extracellular matrix deposition, and contributes to fibrosis developmentHirofumi Niwa, Yosuke Kanno, En Shu, et al.
The Journal of Investigative Dermatology|January 9, 2016
The Antifibrotic Effect of α2AP Neutralization in Systemic Sclerosis Dermal Fibroblasts and Mouse Models of Systemic SclerosisYosuke Kanno, En Shu, Hiroyuki Kanoh, et al.
Archives of Dermatological Research|April 14, 2007
Intraperitoneal injection of pemphigus vulgaris-IgG into mouse depletes epidermal keratinocytes of desmoglein 3 associated with generation of acantholysisEn Shu, Yukari Yamamoto, Yumi Aoyama, et al.
Arthritis Research & Therapy|April 11, 2020
Alternatively activated macrophages are associated with the α2AP production that occurs with the development of dermal fibrosis : The role of alternatively activated macrophages on the development of fibrosisYosuke Kanno, En Shu, Hirofumi Niwa, et al.
Pathophysiology of Haemostasis and Thrombosis|December 8, 2004
Lack of plasminogen activator inhibitor-1 enhances the preventive effect of DX-9065a, a selective factor Xa inhibitor, on venous thrombus and acute pulmonary embolism in miceEn Shu, Hiroyuki Matsuno, Akira Ishisaki, et al.
Arthritis Research & Therapy|February 5, 2017
α2AP regulates vascular alteration by inhibiting VEGF signaling in systemic sclerosis: the roles of α2AP in vascular dysfunction in systemic sclerosisYosuke Kanno, En Shu, Hiroyuki Kanoh, et al.
Molecular Biology Reports|April 29, 2021
MicroRNA-30c attenuates fibrosis progression and vascular dysfunction in systemic sclerosis model miceYosuke Kanno, En Shu, Hirofumi Niwa, et al.
Case Reports in Dermatology|June 6, 2018
Anti-MDA5 Antibody-Positive Dermatomyositis Presenting with Cellulitis-Like Erythema on the Mandible as an Initial SymptomYuki Hattori, Kanako Matsuyama, Tomoko Takahashi, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Life (Basel, Switzerland)|March 25, 2022
α2-Antiplasmin as a Potential Therapeutic Target for Systemic SclerosisYosuke Kanno, En Shu
The Journal of Dermatology|July 22, 2014
Scleroderma renal crisis following pericardial effusion in a Japanese femaleEn Shu, Hiroyuki Kanoh, Mariko Seishima
Molecular Medicine Reports|September 18, 2020
Decrease in matrix metalloproteinase‑3 activity in systemic sclerosis fibroblasts causes α2‑antiplasmin and extracellular matrix deposition, and contributes to fibrosis developmentHirofumi Niwa, Yosuke Kanno, En Shu, et al.
The Journal of Investigative Dermatology|January 9, 2016
The Antifibrotic Effect of α2AP Neutralization in Systemic Sclerosis Dermal Fibroblasts and Mouse Models of Systemic SclerosisYosuke Kanno, En Shu, Hiroyuki Kanoh, et al.
Archives of Dermatological Research|April 14, 2007
Intraperitoneal injection of pemphigus vulgaris-IgG into mouse depletes epidermal keratinocytes of desmoglein 3 associated with generation of acantholysisEn Shu, Yukari Yamamoto, Yumi Aoyama, et al.
Arthritis Research & Therapy|April 11, 2020
Alternatively activated macrophages are associated with the α2AP production that occurs with the development of dermal fibrosis : The role of alternatively activated macrophages on the development of fibrosisYosuke Kanno, En Shu, Hirofumi Niwa, et al.
Pathophysiology of Haemostasis and Thrombosis|December 8, 2004
Lack of plasminogen activator inhibitor-1 enhances the preventive effect of DX-9065a, a selective factor Xa inhibitor, on venous thrombus and acute pulmonary embolism in miceEn Shu, Hiroyuki Matsuno, Akira Ishisaki, et al.
Arthritis Research & Therapy|February 5, 2017
α2AP regulates vascular alteration by inhibiting VEGF signaling in systemic sclerosis: the roles of α2AP in vascular dysfunction in systemic sclerosisYosuke Kanno, En Shu, Hiroyuki Kanoh, et al.
Molecular Biology Reports|April 29, 2021
MicroRNA-30c attenuates fibrosis progression and vascular dysfunction in systemic sclerosis model miceYosuke Kanno, En Shu, Hirofumi Niwa, et al.
Case Reports in Dermatology|June 6, 2018
Anti-MDA5 Antibody-Positive Dermatomyositis Presenting with Cellulitis-Like Erythema on the Mandible as an Initial SymptomYuki Hattori, Kanako Matsuyama, Tomoko Takahashi, et al.
Pageof 4